View Report Details Global Diabetes Market ----------------------------------------------------2014
View Report Details Executive Summary Diabetes, often referred to as diabetes mellitus, describes a group of metabolic diseases in which the person has high blood glucose (blood sugar), either because insulin production is inadequate, or because the body’s cells do not respond properly to insulin, or both. Diabetes is a disorder of metabolism, the process by which the body uses digested food for energy. The digestive tract breaks down carbohydrates, sugars and starches found in many foods, into glucose, a form of sugar that enters the bloodstream. Type 1 diabetes, Type 2 diabetes and Gestational diabetes are the three types of diabetes. There are mainly three types of diabetes treatment which include insulin, oral antidiabetic drug (OAD) and glucagon-like-peptide-1 (GLP-1). The key factors which are anticipated to drive market growth include increasing aging population, rising obese population, rising healthcare expenditure, and continuously surging urban population. Some of the noteworthy developments of this industry include sedentary lifestyle, family history and genetics, among others. However, the industry remains threatened by certain challenges which include high diabetes cost which is a huge burden for families. This report offers a comprehensive analysis of the global diabetes market, along with an in-depth study of the regional market including the US, China, Japan, UK and India. Furthermore, market dynamics such as key trends and development; and challenges are analyzed in depth. On the contention front, the global diabetes market is reined by few major players namely, Novo-Nordisk, Takeda, SanofiAventis and Eli Lilly. The competitive landscape of the respective market, along with the company profiles of the leading players are also discussed in detail. By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the market. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
Diabetes is a disorder of metabolism, the process by which the body uses digested food for energy. •
In 2013, the largest region was Western Pacific which accounted for …% of the global diabetic population followed by South East Asia and Europe which accounted for …% and …% respectively.
•
The global diabetic population increased from …million in 2012 to …million in 2013. The same registered a CAGR of …% for the period 2006-2013. There are several reasons for the increase in worldwide diabetic population. Excessive alcohol intake and smoking increases the risk of diabetes. Smoking makes it harder for the body to properly use insulin. Obesity also results in developing type 2 diabetes. Poor nutrition, particularly a diet high in carbohydrates and sugar, is another risk factor for type 2 diabetes.
•
. The market for diabetes treatment is divided into three segments –oral anti-diabetic drugs (OAD), insulin and glucagon-like-peptide-1 (GLP-1) - each having very different market characteristics. In 2013, insulin accounted for …% of the total diabetes market followed by OAD with …% and GLP-1 with …%.
Global Diabetic Population by Region (2013)
Western Pacific
South East Asia
Europe
North America and Carribean Middle East and North Africa South and Central America Africa
Diabetes Market by Treatment Product (2013)
Millions
Global Diabetic Population (2009-2013)
2009
2010
2011
2012
2013
Insulin
OAD
GLP 1
Some of the noteworthy developments of this industry include rising urban population, rising aging population, rising obese population and rising healthcare expenditures among others. •
As of 2013, the urban population increased at a CAGR of …% over the period 2007-2013. The global urban population has increased from … billion in 2012 to …. billion in 2013. In urban areas, people get better access to education, health facilities, large employment facilities and higher incomes.
•
Insulin is used mostly for intensive diabetes control in patients whose HbA1c levels are very high upon initial diagnosis or in those patients whose diabetic control keeps worsening over time. The insulin market is mainly categorized by molecules which include Glargine, Aspart, RH Insulin, Lispro, Detemir and Glulisin. Glargine held the largest share in insulin market and it accounted for …% share, followed by Aspart with …%.
•
In 2013, long acting insulin accounted for the largest share of …% followed by premix insulin and fast acting insulin with …% and …% respectively.
Billion
Global Urban Population (2007-2013)
2009
2010
2011
2012
2013
Global Insulin Market Share by Molecule (2013)
Global Insulin Market by Segments (2013)
Long Acting Glargine
Aspart
RH insulin
Lispro
Detemir
Glulisine
Fast Acting
Premix
The rising obese population plays a significant role in growth of the global diabetes market.
Millions
Growth in Worldwide Obese Population (2008-2014E)
2008
2009
2010
2011
2012
2013E
The global obese population is projected to grow up to … million in 2013. The worldwide population of obese people has grown by …% during 2005 to 2010, which indicates at the potential of the diabetes market growth. The CAGR for the same was reported at …% for the period spanning from 2007-2013.
•
In 2013, … million people with diabetes were men in comparison with women diabetic population which was … million. Also, … million people have diabetes in urban areas which was higher than rural diabetic population which was … million.
•
The majority of diabetic patients had Type 2 diabetes (… or …%). The proportion of people with diabetes who have type 1 diabetes declined from …% in 2002 to …% in 2013. However, the absolute number of patients with type 1 diabetes continued to increase from … in 2003 to … in 2013. This reflects the rising incidence of type 1 diabetes in children over the last 40 years.
Types of Diabetes in Scotland (2013)
M illions
Diabetes Cases in China- Demographic Trends (2013)
•
Men Total
Women Urban
Rural
Type 2
Type 1
Others
The growth of respective industry is hindered by the barrier for lack of sufficient diagnosis and treatment.
Global Diabetic Population Forecast (2010-2017E)
The prevalence of diabetes in Middle East and North Africa was …% and North America and Caribbean was …% which was the highest in comparison with other regions. The prevalence in South and Central America, Southeast Asia and Western Pacific was …%, …% and …% respectively. Africa accounted for the lowest prevalence of diabetes in 2013.
The global diabetic population witnessed growth from … million in 2012 to … million in 2013 showing a growth of …%. Significant determinants of diabetes are age, body-mass index (BMI), waist-hip ratio, low physical activity, and family history of diabetes. The driving forces behind the epidemic are urbanization and economic development with resultant increase in GDP, sedentary lifestyle, western diet, and fast food diet on a background of genetic susceptibility. Global diabetic population is expected to grow at a CAGR of ….% for the period spanning 2010-2017.
Diabetes market represents moderate share of the total healthcare expenditure but with increasing health awareness, this share is likely to register a significant growth. The diabetes market is likely to benefit from the increasing healthcare expenditure worldwide. In 2007, … per head was spent on healthcare services, and the figure increased to US$... per capita in 2013. The same recorded a CAGR of … % for the aforementioned period. In the coming years, the healthcare expenditure is further expected to increase.
Note: Market attractiveness is inverse of penetration. Low penetration means high attractiveness and vice-versa
2017E
2016E
2015E
2014E
2013
2012
2011
2010
Africa
South & Central America
Middle East & North Africa
North America & Caribbean
Europe
South East Asia
Western Pacific
M illions
Global Diabetes Prevalence Rates (2013)
Contact Us:Details View Report These are abridged and sanitized sample pages from the comprehensive report on the “ Global Diabetes Market Report ”. To know more about this report or for any customized research requirement, please contact the following:
Koncept Analytics
Vikas Gupta BD Manager
CS-36, Second Floor, Ansal Plaza Vaishali, Ghaziabad, U.P. – 201010 T. +91-120-4130959 C: +91-9811715635 vikas@konceptanalytics.com
www.konceptanalytics.com